Abbott Gains Synchrony Accommodating IOL Via $400 Mil. Visiogen Purchase
This article was originally published in The Gray Sheet
Executive Summary
Abbott will strengthen its premium intraocular lens offerings and enter the accommodating IOL market for the first time through its $400 million purchase of Visiogen, announced Sept. 2